Log In
BCIQ
Print this Print this
 

CX2614

  Manage Alerts
Collapse Summary General Information
Company Krenitsky Pharmaceuticals Inc.
DescriptionReversible inhibitor of monoamine oxidase-A (MOA)
Molecular Target Monoamine oxidase (MAO)
Mechanism of ActionMonoamine oxidase (MAO) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDepression
Indication DetailsTreat depression
Regulatory Designation
PartnerCeNeRx BioPharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today